Skip to main content

Site notifications

(Approval Lapsed) Sandoz K-8 Potassium Chloride 600mg Sustained Release tablets

Section 19A approved medicine
(Approval Lapsed) Sandoz K-8 Potassium Chloride 600mg Sustained Release tablets
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
SPAN K potassium chloride 600mg tablet bottle - ARTG 27978
Indication(s)

Treatment of all types of potassium deficiencies, particularly hypochloraemic or hypokalaemic alkalosis associated with prolonged or intensive diuretic therapy, eg. in hypertension, cardiac failure or massive oedema (potassium replacement is particularly important to patients receiving digitalis, as the clinical response to this drug is seriously affected by hypokalaemia), in renal disease associated with increased potassium excretion e.g. nephrotic syndrome; vomiting and diarrhoea, ulcerative colitis, steatorrhoea, diabetes insipidus, and uncontrolled diabetes mellitus; ileostomy or colostomy patients, cirrhosis; Cushing's syndrome and dietary insufficiency; during prolonged or intensive treatment with corticosteroids, ACTH or carbenoxolone; hyperaldosteronism in megaloblastic anaemia, during the early stages of treatment. If a diet rich in potassium cannot be guaranteed.

Help us improve the Therapeutic Goods Administration site